Chronic kidney disease (CKD) affects millions worldwide. It is a long-term condition where the kidneys do not work as well as they are supposed to. Though it is a common condition, many people don ...

Slowing down kidney disease can be life-changing, particularly if it reduces the chances of someone needing dialysis or a kidney transplant.” AstraZeneca’s UK president, Tom Keith-Roach, said: “We are ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Chronic disease isn’t going away ...

AstraZeneca (AZ) has announced that a wider range of chronic kidney disease (CKD) patients across England and Wales will be able to access Forxiga (dapagliflozin), following updated final draft ...

Recognizing it early, treating it promptly and understanding the link to chronic kidney disease (CKD) is key to preserving kidney function and better patient outcomes. AKI and CKD are both forms ...

IgAN affects more than 18,000 people in England. It ranks among the most common causes of chronic kidney disease and kidney failure. Over 4200 people with chronic kidney disease could benefit ...

Jasmine Laws is a US News Reporter at Newsweek based in London, U.K. Her focus is reporting on health insurance, including Medicare and Medicaid, but she also writes about U.S. politics, crime and ...

Do you know someone with kidney disease? The probability is that you do. An estimated 35.5 million adults in this country — that’s 1 in 7 — have chronic kidney disease, although most do ...

London, UK, Friday 30 May 2025 – Today, AstraZeneca announced that the National Institute for Health and Care Excellence (NICE) has published updated Final Draft Guidance recommending Forxiga ...

Ten deer tested positive for chronic wasting disease during the 2024-25 hunting season, mainly in Triad counties. What hunters and farmers need to know about the fatal "zombie deer" disease: ...